GT Biopharma, Inc. (GTBP)
0.299
-0.01
(-2.22%)
USD |
NASDAQ |
Aug 25, 16:00
0.299
0.00 (0.00%)
After-Hours: 18:41
GT Biopharma Total Liabilities (Quarterly) : 2.219M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.219M |
| March 31, 2026 | 2.416M |
| December 31, 2025 | 2.319M |
| September 30, 2025 | 1.321M |
| June 30, 2025 | 31.04M |
| March 31, 2025 | 3.638M |
| December 31, 2024 | 5.902M |
| September 30, 2024 | 4.662M |
| June 30, 2024 | 3.759M |
| March 31, 2024 | 4.60M |
| December 31, 2023 | 6.633M |
| September 30, 2023 | 6.143M |
| June 30, 2023 | 6.381M |
| March 31, 2023 | 7.033M |
| December 31, 2022 | 5.002M |
| September 30, 2022 | 5.117M |
| June 30, 2022 | 8.73M |
| March 31, 2022 | 9.65M |
| December 31, 2021 | 10.26M |
| September 30, 2021 | 3.922M |
| June 30, 2021 | 3.276M |
| March 31, 2021 | 3.626M |
| December 31, 2020 | 35.09M |
| September 30, 2020 | 30.69M |
| June 30, 2020 | 28.56M |
| Date | Value |
|---|---|
| March 31, 2020 | 21.15M |
| December 31, 2019 | 19.71M |
| September 30, 2019 | 18.77M |
| June 30, 2019 | 16.73M |
| March 31, 2019 | 15.52M |
| December 31, 2018 | 14.03M |
| September 30, 2018 | 13.22M |
| June 30, 2018 | 8.952M |
| March 31, 2018 | 5.076M |
| December 31, 2017 | 2.679M |
| September 30, 2017 | 2.802M |
| June 30, 2017 | 20.13M |
| March 31, 2017 | 18.35M |
| December 31, 2016 | 18.95M |
| September 30, 2016 | 17.37M |
| June 30, 2016 | 16.19M |
| March 31, 2016 | 20.26M |
| December 31, 2015 | 50.62M |
| September 30, 2015 | 24.60M |
| June 30, 2015 | 23.03M |
| March 31, 2015 | 51.36M |
| December 31, 2014 | 30.46M |
| September 30, 2014 | 11.61M |
| June 30, 2014 | 7.017M |
| March 31, 2014 | 6.808M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.788M |
| Shareholders Equity (Quarterly) | 3.569M |
| Current Ratio | 2.380 |